Canaf Investments Inc. (TSXV:CAF)

Market Cap	18.26M
Revenue (ttm)	30.68M
Net Income (ttm)	2.46M
Shares Out	47.43M
EPS (ttm)	0.05
PE Ratio	7.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,008
Average Volume	21,010
Open	0.3850
Previous Close	0.3900
Day's Range	0.3850 - 0.3850
52-Week Range	0.2100 - 0.4100
Beta	0.27
RSI	57.13
Earnings Date	Sep 23, 2025

About Checkpoint Therapeutics

Canaf Investments Inc., together with its subsidiaries, owns and operates a coal processing business in South Africa. The company processes anthracite coal into de-volatised anthracite, as well as provides calcined anthracite to steel and ferromanganese manufacturers as a substitute product for coke. It also acquires, redevelops, and rents real estate properties; and invests in the agriculture and food production sector, as well as offers capital for short-term financing to businesses and entrepreneurs. The company was formerly known as Canaf G...

• Industry: Coking Coal
• Sector: Materials
• Founded: 1996
• Employees: 225
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: CAF

Financial Performance

In 2024, Canaf Investments's revenue was 32.72 million, an increase of 1.22% compared to the previous year's 32.33 million. Earnings were 2.16 million, a decrease of -3.44%.